Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7201 USD | +4.00% | -11.13% | -36.27% |
May. 15 | Earnings Flash (XTNT) XTANT MEDICAL HOLDINGS Reports Q1 Revenue $27.9M, vs. Street Est of $25.8M | MT |
May. 15 | Transcript : Xtant Medical Holdings, Inc., Q1 2024 Earnings Call, May 15, 2024 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-36.27% | 93.77M | - | ||
-5.10% | 11.34B | A- | ||
+4.02% | 9.11B | C | ||
+38.12% | 5.53B | B+ | ||
-23.70% | 4.61B | C | ||
+8.55% | 3.45B | C- | ||
-6.44% | 2.87B | B- | ||
-5.85% | 2.1B | - | ||
-11.84% | 2.08B | - | - | |
-23.36% | 1.78B | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- XTNT Stock
- Ratings Xtant Medical Holdings, Inc.